This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer

This study has been completed.
Sponsor:
Collaborator:
Oncology Nursing Society Foundation
Information provided by (Responsible Party):
Yelena Wu, University of Utah
ClinicalTrials.gov Identifier:
NCT01618344
First received: April 25, 2012
Last updated: February 24, 2017
Last verified: February 2017
  Purpose
To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.

Condition
Neoplasms

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Prospective
Official Title: Use of a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by Adolescents and Young Adults(AYA) With Cancer

Further study details as provided by Yelena Wu, University of Utah:

Primary Outcome Measures:
  • Feasibility and acceptability of using a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer. [ Time Frame: ongoing study weeks 5-12 ]

Enrollment: 32
Study Start Date: May 2012
Study Completion Date: February 2017
Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Detailed Description:
Non-adherence to oral medications is a prevalent problem in adolescents and young adults (AYA) with cancer that may impact both survival and quality of life while on treatment. The purpose of this study is to explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer. The study's primary aim is to explore the feasibility and acceptability of using a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer as well as to characterize application use. Secondary aims include: 1) to obtain initial estimates of intervention effect- measured by pre-intervention to post-intervention differences in perceived behavioral control for adherence, intention to adhere, and adherence behavior - to inform design of a future trial powered to detect a clinically significant effect of smart-phone medication reminder application use on adherence to oral medications; and 2) to examine the relationships among perceived behavioral control for adherence, intention to adhere, and adherence behavior. A pre-post single group design will be used. Data will be collected weekly for 4 weeks before introduction of the intervention and for 8 weeks following introduction of the intervention. Analytic approaches will include descriptive statistics and generalized estimating equation (GEE) modeling.
  Eligibility

Ages Eligible for Study:   15 Years to 29 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary care clinics for patients be treated for cancer.
Criteria

Inclusion criteria:

1)15-29 year olds receiving treatment for any type of cancer, either primary or recurrent/relapsed disease.

2) Patient has completed at least one month of therapy

3)Patient is expected to remain on therapy for 3 month duration of study

4) Patient has an iPhone, iPad, or iTouch running iOS 4.0 or later

5) Patient is willing to use a smart-phone medication reminder application-

Exclusion Criteria:

1)Patients who are unable to speak/read/write English as required for use of smart-phone medication reminder application and completion of study measures.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01618344

Locations
United States, Utah
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84112
Sponsors and Collaborators
University of Utah
Oncology Nursing Society Foundation
Investigators
Principal Investigator: Yelena Wu, MD Huntsman Cancer Institute
Principal Investigator: Lauri Linder, PhD University of Utah
  More Information

Responsible Party: Yelena Wu, Principal Investigator, University of Utah
ClinicalTrials.gov Identifier: NCT01618344     History of Changes
Other Study ID Numbers: SCH-13929
Study First Received: April 25, 2012
Last Updated: February 24, 2017

Keywords provided by Yelena Wu, University of Utah:
neoplasms
adolescent
young adult
medication adherence

ClinicalTrials.gov processed this record on August 21, 2017